Combination targeted therapy in chronic lymphocytic leukaemia - can pre-clinical studies translate to the clinic?

被引：0
|
作者：
Ioannou, Nikolaos [1 ]
Ramsay, Alan G. [1 ]
机构：
[1] Kings Coll London, Fac Life Sci & Med, Sch Canc & Pharmaceut Sci, Lymphoma Immunol Grp, London, England
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2018年 / 182卷 / 03期
关键词：
targeted therapy; chronic lymphocytic leukaemia; microenvironment; CELLS;
D O I：
10.1111/bjh.15279
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：315 / 316
页数：2
相关论文
共 50 条
  • [41] Anti-Netrin-1 Therapy Sensitizes Pancreatic Cancer to Immune Checkpoint Inhibition: Pre-Clinical Studies to Support Translation to the Clinic
    Casabianca, A.
    Dudgeon, C.
    Soliman, F.
    Withers, T.
    Mehlen, P.
    Carpizo, D.
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (SUPPL 1) : S93 - S93
  • [42] Clinical Observations of AML Expressing Mutant RUNX1 and Pre-Clinical Studies of RUNX1-Targeted Novel Therapy of AML.
    DiNardo, Courtney
    Mill, Christopher
    Fiskus, Warren
    Saenz, Dyana
    Nowak, Agnieszka
    Sun, Baohua
    Patel, Keyur
    Kadia, Tapan
    Benton, Christopher
    Takahashi, Koichi
    Kantarjian, Hagop
    Bhalla, Kapil
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 : S296 - S296
  • [43] Clinical observations of AML expressing mutant RUNX1 and pre-clinical studies of RUNX1-targeted novel therapy of AML.
    Dinardo, Courtney Denton
    Mill, Christopher P.
    Fiskus, Warren
    Saenz, Dyana T.
    Nowak, Agnieszka J.
    Sun, Baohua
    Patel, Keyur
    Kadia, Tapan M.
    Benton, Christopher Brent
    Takahashi, Koichi
    Kantarjian, Hagop M.
    Bhalla, Kapil N.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [44] Indatuximab ravtansine (BT062) combination treatment in multiple myeloma: pre-clinical studies
    Schoenfeld, Kurt
    Zuber, Chantal
    Pinkas, Jan
    Haeder, Thomas
    Bernoester, Katrin
    Uherek, Christoph
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2017, 10
  • [45] The TCL-1 transgenic mouse is an effective tool for pre-clinical drug development in chronic lymphocytic leukemia
    Johnson, AJ
    Edwards, R
    Smith, LL
    Lucas, DM
    Croce, CM
    Muthusamy, N
    Chen, CS
    Liu, ZF
    Chan, K
    Grever, MR
    Byrd, JC
    BLOOD, 2005, 106 (11) : 20A - 20A
  • [46] Indatuximab ravtansine (BT062) combination treatment in multiple myeloma: pre-clinical studies
    Kurt Schönfeld
    Chantal Zuber
    Jan Pinkas
    Thomas Häder
    Katrin Bernöster
    Christoph Uherek
    Journal of Hematology & Oncology, 10
  • [47] The Cyclin Dependent Kinase Inhibitor SCH 727965 Demonstrates Promising Pre-Clinical and Early Clinical Activity in Chronic Lymphocytic Leukemia
    Flynn, Joseph M.
    Johnson, Amy J.
    Andritsos, Leslie
    Blum, Kristie A.
    Jones, Jeffrey A.
    Wiley, Elizabeth A.
    Hu, Weihong
    Hessler, Joshua
    Smith, Lisa L.
    Lucas, David M.
    Small, Karen
    Statkevich, Paul
    Grever, Michael R.
    Bannerji, Rajat
    Byrd, John C.
    BLOOD, 2009, 114 (22) : 365 - 365
  • [48] Ipatasertib, an oral AKT inhibitor, in combination with Bevacizumab exhibits anti-tumorigenic effects in pre-clinical studies for endometrioid endometrial cancer: Endometrial Cancer Molecularly Targeted Therapy Consortium
    Newton, Meredith
    Burkett, Wesley
    Zhao, Ziyi
    Secord, Angeles Alvarez
    Zhou, Chunxiao
    Bae-Jump, Victoria
    GYNECOLOGIC ONCOLOGY, 2022, 166 : S31 - S31
  • [49] The innate immune system and neurogenesis as modulating mechanisms of electroconvulsive therapy in pre-clinical studies
    Giacobbe, Juliette
    Pariante, Carmine M.
    Borsini, Alessandra
    JOURNAL OF PSYCHOPHARMACOLOGY, 2020, 34 (10) : 1086 - 1097
  • [50] The CMAM facility for proton-therapy pre-clinical studies: biomaterial irradiation experiments
    Vinals, S.
    Garcia, G.
    Magro, R.
    Manso, M.
    JOURNAL OF INSTRUMENTATION, 2023, 18 (03)
12345